Laxicaps P
Phenolphthalein
Every registration of this product has been cancelled.
The register's composition for this product is incomplete, so it is not grouped under a compound.
EACH CAPSULE CONTAINS PHENOLPHTHALEIN 125,0 mg YELLOW
3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1-one
Drag to rotate. Structure from PubChem CID 4764.
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| The Premier Pharmaceutical Co LtdCancelled | Laxicaps p | Not stated | 310437 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Laxicaps p EACH CAPSULE CONTAINS PHENOLPHTHALEIN 125,0 mg YELLOW | Not listed | 31043731/11.5/0437 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.